High mobility group protein B1 is a predictor of poor survival in ovarian cancer

High-mobility group protein B1 (HMGB1) has been implicated in numerous tumour types where expression regulates tumour cell growth and survival. We hypothesised that high HMGB1 expression in ovarian tumours would predict poor patient survival. Using tissue microarrays of primary ovarian cancers combi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Machado, Lee R., Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher, Spendlove, Ian, Ramage, Judith M., Chan, Stephen YT., Durrant, Lindy G.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731868/
https://ncbi.nlm.nih.gov/pubmed/29254158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20538
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires